Next Article in Journal
MOGAT2: A New Therapeutic Target for Metabolic Syndrome
Next Article in Special Issue
An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases
Previous Article in Journal
Endovascular Repair of Aortic Dissection in Marfan Syndrome: Current Status and Future Perspectives

Metabolomic Approaches in Cancer Epidemiology

Methods and Technologies Branch, Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Suite 4E102, 9609 Medical Center Drive, Bethesda, MD 20892, USA
Department of Biological and Pharmaceutical Sciences, Elizabeth City State University, Campus Box 930, 1704 Weeksville Road, Elizabeth City, NC 27909, USA
Author to whom correspondence should be addressed.
Academic Editor: Liang Zhao
Diseases 2015, 3(3), 167-175;
Received: 19 June 2015 / Revised: 30 July 2015 / Accepted: 31 July 2015 / Published: 11 August 2015
(This article belongs to the Special Issue Advances and Applications of Metabolomics in Human Diseases)
Metabolomics is the study of low molecular weight molecules or metabolites produced within cells and biological systems. It involves technologies such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR) that can measure hundreds of thousands of unique chemical entities (UCEs). The metabolome provides one of the most accurate reflections of cellular activity at the functional level and can be leveraged to discern mechanistic information during normal and disease states. The advantages of metabolomics over other “omics” include its high sensitivity and ability to enable the analysis of relatively few metabolites compared with the number of genes and messenger RNAs (mRNAs). In clinical samples, metabolites are more stable than proteins or RNA. In fact, metabolomic profiling in basic, epidemiologic, clinical, and translational studies has revealed potential new biomarkers of disease and therapeutic outcome and has led to a novel mechanistic understanding of pathogenesis. These potential biomarkers include novel metabolites associated with cancer initiation, regression, and recurrence. Unlike genomics or even proteomics, however, the degree of metabolite complexity and heterogeneity within biological systems presents unique challenges that require specialized skills and resources to overcome. This article discusses epidemiologic studies of altered metabolite profiles in several cancers as well as challenges in the field and potential approaches to overcoming them. View Full-Text
Keywords: biomarker; cohort; epidemiology; metabolomics biomarker; cohort; epidemiology; metabolomics
MDPI and ACS Style

Verma, M.; Banerjee, H.N. Metabolomic Approaches in Cancer Epidemiology. Diseases 2015, 3, 167-175.

AMA Style

Verma M, Banerjee HN. Metabolomic Approaches in Cancer Epidemiology. Diseases. 2015; 3(3):167-175.

Chicago/Turabian Style

Verma, Mukesh; Banerjee, Hirendra N. 2015. "Metabolomic Approaches in Cancer Epidemiology" Diseases 3, no. 3: 167-175.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop